← Back to Clinical Trials
Recruiting NCT06688214

NCT06688214 Effects of KT and Scapular Stabilization Exercises.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06688214
Status Recruiting
Phase
Sponsor Sehat Medical Complex
Condition Subacromial Impingement Syndrome
Study Type INTERVENTIONAL
Enrollment 34 participants
Start Date 2024-11-30
Primary Completion 2025-05-25

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 55 Years
Study Type INTERVENTIONAL
Interventions
Kinesio Taping treatmentScapular Stabilization Exercises

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 34 participants in total. It began in 2024-11-30 with a primary completion date of 2025-05-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The distance between the acromion bone and the head of the humerus narrows in subacromial impingement syndrome. This narrowing leads to the compression of sensitive structures and results in pain and decreased functional performance.While taping and scapular stabilizing exercises are commonly used in the treatment of subacromial impingement syndrome, no comparisons were conducted previously between their effectiveness. This randomized clinical trial will be conducted at Punjab Sports Board, Lahore.This study will include patients with age group ≥18 years; pain located on the anterolateral side of the shoulder for ≥3 months with positive clinical signs. Group A will receive Kinesiotaping protocol and Group B will receive Scapular Stabilization exercises protocol.

Eligibility Criteria

Inclusion Criteria: Participants with age between 18 to 55 years. Participants with pain on the anterolateral side of the shoulder for ≥3 months. Participants diagnosed with ≥3 positive clinical signs of SIS, such as the Neer or Hawkins-Kennedy test, a painful arc by a sports physical therapist. Mild or Moderate pain on resisted external rotation, or the Empty Can test. Exclusion Criteria: Diagnosis of cervical radiculopathy. Participants with osteoarthritis in the acromioclavicular or glenohumeral joint. Calcific tendinitis, adhesive capsulitis, glenohumeral instability or a partial or full-thickness rotator cuff tear, clinical history of acute trauma, previous surgery or previous fracture in the affected shoulder. Corticosteroid injection into the shoulder joint in the previous 12 months.

Contact & Investigator

Central Contact

Imran Ghafoor Dr., DPT, M.phill

✉ imran.ghafoor@riphah.edu.pk

📞 +923344292887

Principal Investigator

Imran Ghafoor Dr., DPT,M.phil

STUDY CHAIR

Riphah International University

Frequently Asked Questions

Who can join the NCT06688214 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Subacromial Impingement Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06688214 currently recruiting?

Yes, NCT06688214 is actively recruiting participants. Contact the research team at imran.ghafoor@riphah.edu.pk for enrollment information.

Where is the NCT06688214 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT06688214 clinical trial?

NCT06688214 is sponsored by Sehat Medical Complex. The principal investigator is Imran Ghafoor Dr., DPT,M.phil at Riphah International University. The trial plans to enroll 34 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology